Evaluating modes of influenza transmission (EMIT-2): Insights from lack of transmission in a controlled transmission trial with naturally infected donors
PLOS Pathogens · 07.01.2026 · 22 (1) · e1013153
DOI: 10.1371/journal.ppat.1013153 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 07.01.2026. Verfasst von Jianyu Lai und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global, Environmental, and Occupational Health, School of Public Health, University of Maryland, College Park, Maryland, United States …. Hauptthemen laut MEDLINE: Influenza, Human, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Institute for Clinical and Translational Research, University of Maryland, Baltimore.
Abstract (Originalsprache)
A previous controlled human influenza transmission trial produced minimal transmission using nasal inoculation of an egg adapted virus. Therefore, we implemented a new trial with naturally infected Donors. We recruited healthy Recipients for four, two-week hotel quarantine cohorts and naturally infected, qRT-PCR confirmed Donors for two cohorts. Five Donors (mean age: 21; 80% female; two H1N1, three H3N2, one for cohort 24b and 4 for 24c, Jan-Feb 2024) exposed Recipients (mean age: 36; 54% female, eight in cohort 24b and 3 in 24c) in a hotel room with limited ventilation but a high air recirculation rate. We collected exhaled breath, ambient and personal bioaerosols, fomite swabs, and sera, and analyzed samples using dPCR and fluorescent focus assays, hemagglutination inhibition (HAI) assay, and enzyme-linked immunosorbent assay (ELISA). Compared with previously studied community-acquired influenza cases, we detected viral RNA (44%) and culturable virus (6%) less frequently and measured fewer viral RNA copies (79 – 8.9 × 10 3 copies/30-min) in Donors’ exhaled fine aerosols. One of 23 surface swab samples was culture positive. At admission, 8 of 11 Recipients had HAI titers ≤10 but 9 of 11 had stronger binding antibody responses than Donors against vaccine strains corresponding to Donor viruses. No Recipient developed influenza-like illness, PCR-positive respiratory samples, or serological evidence of infection. Potential explanations and insights regarding lack of transmission include importance of cough and seasonal variation in viral aerosol shedding by Donors, of potential cross-reactive immunity in middle-aged Recipients with decades of exposure, and of exposure to concentrated exhaled breath plumes limited by rapid air mixing from environmental controls that distributed aerosols evenly. Future trials over multiple seasons, Donors that cough, younger recipients, and environments that preserve normal exhaled breath plumes will be required to observe transmission from naturally infected Donors under controlled conditions and generate new insights into influenza transmission dynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Global, Environmental, and Occupational Health, School of Public Health, University of Maryland, College Park, Maryland, United States of America.
- Department of Mechanical Engineering, University of Maryland, College Park, Maryland, United States of America.
- Fischell Institute for Biomedical Devices, University of Maryland, College Park, Maryland, United States of America.
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
- Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
ORCID-Profile: Donald K Milton
Förderung
- NIAID NIH HHS
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
- Institute for Clinical and Translational Research, University of Maryland, Baltimore
- Flu Lab
- Balvi Filanthropic Fund
Zitieren
APA
Lai, J., Sobhani, H., Coleman, K. K., Tai, S. S., Hong, F., Sierra Maldonado, I., Esparza, Y., McPhaul, K. M., Zhu, S., DeVoe, D. L., Ortiz, J. R., Chen, S., Yellin, T., Carreno, J. M., Krammer, F., Cowling, B. J., Gordon, A., Chen, W. H., Srebric, J., …, & EMIT-2 Study Team (2026). Evaluating modes of influenza transmission (EMIT-2): Insights from lack of transmission in a controlled transmission trial with naturally infected donors. PLOS Pathogens, 22(1), e1013153. https://doi.org/10.1371/journal.ppat.1013153
Vancouver
Lai J, Sobhani H, Coleman KK, Tai SS, Hong F, Sierra Maldonado I, et al. Evaluating modes of influenza transmission (EMIT-2): Insights from lack of transmission in a controlled transmission trial with naturally infected donors. PLOS Pathogens. 2026;22(1):e1013153. doi:10.1371/journal.ppat.1013153
BibTeX
@article{Lai2026,
author = {Lai, Jianyu and Sobhani, Hamed and Coleman, Kristen K and Tai, Shih-Han Sheldon and Hong, Filbert and Sierra Maldonado, Isabel and Esparza, Yi and McPhaul, Kathleen M and Zhu, Shengwei and DeVoe, Don L and Ortiz, Justin R and Chen, Shuo and Yellin, Temima and Carreno, Juan Manuel and Krammer, Florian and Cowling, Benjamin J and Gordon, Aubree and Chen, Wilbur H and Srebric, Jelena and Milton, Donald K and EMIT-2 Study Team, EMIT-2 Study Team},
title = {Evaluating modes of influenza transmission (EMIT-2): Insights from lack of transmission in a controlled transmission trial with naturally infected donors},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {1},
pages = {e1013153},
doi = {10.1371/journal.ppat.1013153}
}
EUVIMED